John M. Leonard, President and CEO at Intellia Therapeutics, Inc. (NTLA), sold 13,346 shares at $37.21 ($497K) on 2023-01-04, disclosed to the SEC on 2023-01-06.
Open-market sale of $497k NTLA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.21 | 6,673 | $248K | 50.0% |
| 2 | $37.21 | 6,673 | $248K | 50.0% |
| Total | $37.21 avg | 13,346 | $497K | 100% |
| Filing → |
| NTLA | SELL | 2025-12-12 | $1.7M | — | Filing → |
| NTLA | SELL | 2025-01-07 | $653K | — | Filing → |
| NTLA | SELL | 2024-01-05 | $1.1M | — | Filing → |